Annual D&A
$340.70 K
+$1900.00+0.56%
01 December 2023
Summary:
Addex Therapeutics Ltd annual depreciation & amortization is currently $340.70 thousand, with the most recent change of +$1900.00 (+0.56%) on 01 December 2023. During the last 3 years, it has fallen by -$63.30 thousand (-15.67%). ADXN annual D&A is now -89.72% below its all-time high of $3.31 million, reached on 31 December 2011.ADXN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$121.60 K
+$41.10 K+51.06%
01 June 2024
Summary:
Addex Therapeutics Ltd quarterly depreciation & amortization is currently $121.60 thousand, with the most recent change of +$41.10 thousand (+51.06%) on 01 June 2024. Over the past year, it has increased by +$33.30 thousand (+37.71%). ADXN quarterly D&A is now at all-time high.ADXN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$374.60 K
+$35.20 K+10.37%
01 June 2024
Summary:
Addex Therapeutics Ltd TTM depreciation & amortization is currently $374.60 thousand, with the most recent change of +$35.20 thousand (+10.37%) on 01 June 2024. Over the past year, it has increased by +$35.50 thousand (+10.47%). ADXN TTM D&A is now -9.19% below its all-time high of $412.50 thousand, reached on 30 September 2020.ADXN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADXN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.6% | +37.7% | +10.5% |
| 3 y3 years | -15.7% | +29.4% | -0.1% |
| 5 y5 years | +10000.0% | +44.1% | +55.6% |
ADXN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -15.7% | +0.6% | at high | +52.2% | -1.5% | +14.7% |
| 5 y | 5 years | -15.7% | >+9999.0% | at high | +52.2% | -9.2% | +55.6% |
| alltime | all time | -89.7% | >+9999.0% | at high | +58.5% | -9.2% | +388.4% |
Addex Therapeutics Ltd Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $121.60 K(+51.1%) | $374.60 K(+10.4%) |
| Mar 2024 | - | $80.50 K(-4.4%) | $339.40 K(-0.4%) |
| Dec 2023 | $340.70 K(+0.6%) | $84.20 K(-4.6%) | $340.70 K(+0.5%) |
| Sept 2023 | - | $88.30 K(+2.2%) | $339.10 K(+2.5%) |
| June 2023 | - | $86.40 K(+5.6%) | $330.70 K(+1.3%) |
| Mar 2023 | - | $81.80 K(-1.0%) | $326.60 K(-3.6%) |
| Dec 2022 | $338.80 K(-10.9%) | $82.60 K(+3.4%) | $338.80 K(-2.7%) |
| Sept 2022 | - | $79.90 K(-2.9%) | $348.30 K(-3.9%) |
| June 2022 | - | $82.30 K(-12.4%) | $362.40 K(-3.7%) |
| Mar 2022 | - | $94.00 K(+2.1%) | $376.30 K(-1.1%) |
| Dec 2021 | $380.30 K(-5.9%) | $92.10 K(-2.0%) | $380.30 K(+1.4%) |
| Sept 2021 | - | $94.00 K(-2.3%) | $375.00 K(-5.8%) |
| June 2021 | - | $96.20 K(-1.8%) | $398.30 K(-1.1%) |
| Mar 2021 | - | $98.00 K(+12.9%) | $402.60 K(-0.3%) |
| Dec 2020 | $404.00 K | $86.80 K(-26.0%) | $404.00 K(-2.1%) |
| Sept 2020 | - | $117.30 K(+16.7%) | $412.50 K(+8.7%) |
| June 2020 | - | $100.50 K(+1.1%) | $379.60 K(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $99.40 K(+4.3%) | $358.70 K(+6.8%) |
| Dec 2019 | $336.00 K(>+9900.0%) | $95.30 K(+12.9%) | $336.00 K(+39.6%) |
| Sept 2019 | - | $84.40 K(+6.0%) | $240.70 K(+54.0%) |
| June 2019 | - | $79.60 K(+3.8%) | $156.30 K(+103.8%) |
| Mar 2019 | - | $76.70 K | $76.70 K |
| Dec 2018 | $3000.00(-80.6%) | - | - |
| Dec 2017 | $15.50 K(-40.8%) | - | - |
| Dec 2016 | $26.20 K(-2.6%) | - | - |
| Dec 2015 | $26.90 K(-77.7%) | - | - |
| Dec 2014 | $120.50 K(-83.1%) | - | - |
| Dec 2013 | $715.00 K(-68.1%) | - | - |
| Dec 2012 | $2.24 M(-32.3%) | - | - |
| Dec 2011 | $3.31 M(+18.0%) | - | - |
| Dec 2010 | $2.81 M(+7.3%) | - | - |
| Dec 2009 | $2.62 M(+40.3%) | - | - |
| Dec 2008 | $1.87 M(+24.2%) | - | - |
| Dec 2007 | $1.50 M(-25.4%) | - | - |
| Dec 2006 | $2.01 M | - | - |
FAQ
- What is Addex Therapeutics Ltd annual depreciation & amortization?
- What is the all time high annual D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual D&A year-on-year change?
- What is Addex Therapeutics Ltd quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly D&A year-on-year change?
- What is Addex Therapeutics Ltd TTM depreciation & amortization?
- What is the all time high TTM D&A for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd TTM D&A year-on-year change?
What is Addex Therapeutics Ltd annual depreciation & amortization?
The current annual D&A of ADXN is $340.70 K
What is the all time high annual D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual depreciation & amortization is $3.31 M
What is Addex Therapeutics Ltd annual D&A year-on-year change?
Over the past year, ADXN annual depreciation & amortization has changed by +$1900.00 (+0.56%)
What is Addex Therapeutics Ltd quarterly depreciation & amortization?
The current quarterly D&A of ADXN is $121.60 K
What is the all time high quarterly D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly depreciation & amortization is $121.60 K
What is Addex Therapeutics Ltd quarterly D&A year-on-year change?
Over the past year, ADXN quarterly depreciation & amortization has changed by +$33.30 K (+37.71%)
What is Addex Therapeutics Ltd TTM depreciation & amortization?
The current TTM D&A of ADXN is $374.60 K
What is the all time high TTM D&A for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high TTM depreciation & amortization is $412.50 K
What is Addex Therapeutics Ltd TTM D&A year-on-year change?
Over the past year, ADXN TTM depreciation & amortization has changed by +$35.50 K (+10.47%)